How can we improve deprescribing communication among patients with dementia and multiple chronic conditions?
A qualitative study in primary care lends key insights.
Green AR, et al. Designing a Primary Care-Based Deprescribing Intervention for Patients with Dementia and Multiple Chronic Conditions: A Qualitative Study. J Gen Intern Med.
When it’s better to stop or decrease health care services and interventions: researchers bring validity and transparency to deintensification recommendations in primary care.
Kerr EA, et al. Identifying recommendations for stopping or scaling back unnecessary routine services in primary care. JAMA Intern Med. 2020;180(11):1500-1508. doi:10.1001/jamainternmed.2020.4001 A recent study
Aubert C, et al. Outcome Measures for Interventions to Reduce Inappropriate Chronic Drugs: A Narrative Review. J Am Geriatr Soc. 2020; doi: 10.1111/jgs.16697 A new
The OPTIMISE Randomized Clinical Trial: Deprescribing Antihypertensive Medications in Adults Aged 80 and Older and its Effect on Blood Pressure
Sheppard J, et al. Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients with Hypertension Aged 80 Years and
The IMPACT Collaboratory released two new Requests for Applications (RFAs) for conducting pragmatic trials in persons with AD/ADRD on April 20: Request for Applications for
COVID-19 response in post-acute and long-term care: Task force develops new guide to optimize medications.
A task force convened by the Peter Lamy Center on Drug Therapy and Aging at the University of Maryland School of Pharmacy with assistance from